Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Gimeracil Impurity 21 REF: 4Z-G-047026CAS: 149143-67-9	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Palbociclib Impurity 43 REF: 4Z-P-196088	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 77 REF: 4Z-P-196084	- - -	To inquire	Tue 10 Dec 24
Tamoxifen EP Impurity G REF: 4Z-T-0118CAS: 68047-07-4	- - -	To inquire	Tue 10 Dec 24
Oxo-2-pyridinylaminoacetic Acid REF: 4Z-G-047008CAS: 16817-89-3	- - -	To inquire	Tue 10 Dec 24
Tamoxifen EP Impurity B REF: 4Z-T-0114CAS: 748-97-0	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 29 REF: 4Z-E-068042CAS: 1187368-67-7	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 13 REF: 4Z-G-047015CAS: 529-19-1	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 29 REF: 4Z-P-196033	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 14 REF: 4Z-A-8251CAS: 93830-58-1	- - -	To inquire	Tue 10 Dec 24
4'-Hydroxytamoxifen REF: 4Z-T-0112CAS: 82413-23-8	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 23 REF: 4Z-N-066039CAS: 119-63-1	- - -	To inquire	Tue 10 Dec 24
Lenvatinib mesylate REF: TM-T8541CAS: 857890-39-2	99.03% - 99.79%	40.00 €~263.00 €	Tue 10 Dec 24
Bestatin Impurity 8 HCl REF: 4Z-B-119011CAS: 67617-35-0	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 19 REF: 4Z-P-196023CAS: 2324831-15-2	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 61 REF: 4Z-C-121064	- - -	To inquire	Tue 10 Dec 24
Folitixorin (Mixture of Diastereomers) REF: 4Z-F-068024CAS: 3432-99-3	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 22 REF: 4Z-O-032024	- - -	To inquire	Tue 10 Dec 24
Gimeracil REF: 4Z-G-047029CAS: 103766-25-2	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 19 REF: 4Z-L-124024	- - -	To inquire	Tue 10 Dec 24

10mg		40.00 €
25mg		59.00 €
50mg		87.00 €
100mg		109.00 €
200mg		162.00 €
500mg		263.00 €

Cancer treatment

Gimeracil Impurity 21

Ref: 4Z-G-047026

N-Nitroso Palbociclib Impurity 43

Ref: 4Z-P-196088

Palbociclib Impurity 77

Ref: 4Z-P-196084

Tamoxifen EP Impurity G

Ref: 4Z-T-0118

Oxo-2-pyridinylaminoacetic Acid

Ref: 4Z-G-047008

Tamoxifen EP Impurity B

Ref: 4Z-T-0114

Enzalutamide Impurity 29

Ref: 4Z-E-068042

Gimeracil Impurity 13

Ref: 4Z-G-047015

Palbociclib Impurity 29

Ref: 4Z-P-196033

Abiraterone Impurity 14

Ref: 4Z-A-8251

4'-Hydroxytamoxifen

Ref: 4Z-T-0112

Nintedanib Impurity 23

Ref: 4Z-N-066039

Lenvatinib mesylate

Ref: TM-T8541

Bestatin Impurity 8 HCl

Ref: 4Z-B-119011

Palbociclib Impurity 19

Ref: 4Z-P-196023

Carfilzomib Impurity 61

Ref: 4Z-C-121064

Folitixorin (Mixture of Diastereomers)

Ref: 4Z-F-068024

Olaparib Impurity 22

Ref: 4Z-O-032024

Gimeracil

Ref: 4Z-G-047029

Lenvatinib Impurity 19

Ref: 4Z-L-124024